Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia (2022)
- Authors:
- USP affiliated authors: REGO, EDUARDO MAGALHÃES - FM ; MACHADO NETO, JOÃO AGOSTINHO - ICB ; SILVA, JEAN CARLOS LIPRERI DA - ICB ; VICARI, HUGO PASSOS - ICB
- Unidades: FM; ICB
- DOI: 10.1016/j.lfs.2022.121146
- Subjects: FARMACOLOGIA; DOENÇAS HEMATOLÓGICAS; LEUCEMIA; LINFÓCITOS B; ONCOGENES; CÉLULAS CULTIVADAS DE TUMOR; APOPTOSE; LINFOMA; MEMBRANA PLASMÁTICA
- Keywords: NEOPLASIAS SANGUINEAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2022
- Source:
- Título: Life Sciences
- ISSN: 1879-0631
- Volume/Número/Paginação/Ano: v. 311, part B, art. 121146, p. 1-9, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Jean Carlos Lipreri da et al. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sciences, v. 311, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2022.121146. Acesso em: 08 out. 2024. -
APA
Silva, J. C. L. da, Araujo, F. S., Melo, R. C. B. de, Vicari, H. P., Carvalho, A. E. S., Rego, E. M., et al. (2022). Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia. Life Sciences, 311, 1-9. doi:10.1016/j.lfs.2022.121146 -
NLM
Silva JCL da, Araujo FS, Melo RCB de, Vicari HP, Carvalho AES, Rego EM, Buccheri V, Machado Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia [Internet]. Life Sciences. 2022 ; 311 1-9.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.lfs.2022.121146 -
Vancouver
Silva JCL da, Araujo FS, Melo RCB de, Vicari HP, Carvalho AES, Rego EM, Buccheri V, Machado Neto JA. Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia [Internet]. Life Sciences. 2022 ; 311 1-9.[citado 2024 out. 08 ] Available from: https://doi.org/10.1016/j.lfs.2022.121146 - Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
- CDC7 (cell division cycle 7)
- Synthetic cyclopenta[b]indoles exhibit antineoplastic activity by targeting microtubule dynamics in acute myeloid leukemia cells
- Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia
- Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents
- Inibição farmacológica de ezrina reduz a viabilidade, a clonogenicidade e a ativação da via PI3K/AKT/mTOR em modelos celulares de leucemia mieloide aguda
- Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms
- NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells
- ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
- STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells
Informações sobre o DOI: 10.1016/j.lfs.2022.121146 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
